Establishment of the enzyme-linked immunosorbent assay system to detect the amino terminal secretory form of rat Erc/Mesothelin

Cancer Science

Volumn 98, Issue 5, 2007, Pages 659-664

  Nakaishi, Masayuki ^a   Kajino, Kazunori ^b   Ikesue, Masahiro ^c   Hagiwara, Yoshiaki ^c   Kuwahara, Maki ^d   Mitani, Hiroaki ^e   Horikoshi sakuraba, Yuko ^c   Segawa, Tatsuya ^c   Kon, Shigeyuki ^f   Maeda, Masahiro ^c   Wang, Tegexibaiyin ^b   Abe, Masaaki ^b   Yokoyama, Masayoshi ^a   Hino, Okio ^b  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Immuno Biological Laboratories Co Ltd   (Japan)

^d INSTITUTE OF ENVIRONMENTAL TOXICOLOGY   (Japan)

^e CANCER INSTITUTE   (Japan)

^f HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MESOTHELIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER TRANSPLANTATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALIGNANT MESOTHELIOMA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MESOTHELIOMA; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NEOPLASMS, EXPERIMENTAL; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 34147114938     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00438.x     Document Type: Article

References (23)

1. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30.
2. Hino O, Kobayashi E, Nishizawa M et al. Renal carcinogenesis in the Eker rat. J Cancer Res Clin Oncol 1995; 121: 602-5.
3. Hough CD, Sherman-Baust CA, Pizer ES et al. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000; 60: 6281-7.
4. Argani P, Iacobuzio-Donahue C, Ryu B et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 2001; 7: 3862-8.
5. Chang K, Pastan I. Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line. Int J Cancer 1994; 57: 90-7.
6. Yamashita Y, Yokoyama M, Kobayashi E, Takai S, Hino O. Mapping and determination of the cDNA sequence of the Erc gene preferentially expressed in renal cell carcinoma in the Tsc2 gene mutant (Eker) rat model. Biochem Biophys Res Commun 2000; 275: 134-40.
7. Onda M, Nagata S, Ho M et al. Megakaryocyte potentiation factor cleaved from Mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma. Clin Cancer Res 2006; 12: 4225-31.
8. Shiomi K, Miyamoto H, Segawa T et al. Novel ELISA system for detection of N-ERC/Mesothelin in the sera of mesothelioma patients. Cancer Sci 2006; 97: 928-32.
9. Scholler N, Fu N, Yang Y et al. Soluble member(s) of the mesothelin/ megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Natl Acad Sci USA 1999; 96: 11 531-6.
10. Robinson BWS, Creaney J, Lake R et al. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 2003; 362: 1612-6.
11. Robinson BWS, Creaney J, Lake R et al. Soluble mesothelin-related protein - a blood test for mesothelioma. Lung Cancer 2005; 49S1: S109-11.
12. Hassan R, Remaley AT, Sampson ML. Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res 2006; 12: 447-53.
13. Kobayashi T, Hirayama Y, Kobayashi E, Kubo Y, Hino O. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet 1995; 9: 70-4.
14. Kuwahara M, Inui K, Sugimoto K et al. Establishment and characterization of spontaneous mesothelioma cell lines derived from F344 rats. Virchows Arch 1997; 431: 257-63.
15. Kojima T, Oh-eda M, Hattori K et al. Molecular cloning and expression of megakaryocyte potentiating factor cDNA. J Biol Chem 1995; 270: 21 984-90.
16. Chang K, Pai LH, Batra JK, Pastan I, Willingham MC. Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium. Cancer Res 1992; 52: 182-6.
17. Chang K, Pastan I, Willingham MC. Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium. Int J Cancer 1992; 50: 373-81.
18. Yamaguch N, Hattori K, Oeda M, Kojima T, Imai N, Ochi N. A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5. J Biol Chem 1994; 269: 805-8.
19. Fukuda T, Hirayama Y, Mitani H et al. Generation of metastatic variants of Eker renal carcinoma cell lines for experimental investigation of renal cancer metastasis. Jpn J Cancer Res 1998; 89: 1104-8.
20. Mekawa Y, Kurokawa Y, Takahashi M et al. Spontaneous tumors in F-344/ DuCrj rats. Gann 1983; 74: 365-72.
21. Maita K, Hirano M, Harada T et al. Spontaneous tumors in F-344/DuCrj rats from 12 control groups of chronic and oncogenicity studies. J Toxicol Sci 1987; 12: 111-26.
22. Craighead JE, Akley NJ, Gould LB, Libbus BL. Characteristics of tumors and tumor cells cultured from experimental asbestos-induced mesotheliomas in rats. Am J Pathol 1987; 129: 448-62.
23. Manning LS, Whitaker D, Murch AR et al. Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions. Int J Cancer 1991; 47: 285-90.